Preview

Russian Journal of Transplantology and Artificial Organs

Advanced search

QUALITY OF LIFE ASSESSMENT IN CARDIAC TRANSPLANT RECIPIENTS

https://doi.org/10.15825/1995-1191-2014-4-11-16

Abstract

Background. Quality of life (QoL) is an important criterion for the treatment effi cacy that provides an important data regarding patient’s personal estimation of social adaptation and ability to perform daily duties.

Methods. The study was aimed to evaluate QoL in cardiac transplant recipients. We have enrolled 42 stage D heart failure patients aged 29–61 (mean 39,23 ± 12,31 y/o), 38 males and 4 females, survived cardiac transplant surgery between Jan 2008 and Jan 2013. QoL was evaluated using the SF-36 survey prior to the heart surgery and during the follow-up period up to the 5 years.

Results. Pre-operative assessment revealed low QoL indices of physical activity as well as general health status. Follow-up showed dramatic improvement in all QoL measures during 1 year after the surgery which was consistent through the whole observation period. There was an increase in physical functioning index by 2,8 times (p < 0,01), physical status dependent role functioning by 14 times (р < 0,0001), emotional status dependent role functioning by 3 times (р = 0,02), social functioning by 4,8 times (p = 0,002), pain threshold by 3 times (p = 0,02), psychic health by 3,6 times (p = 0,001), life activity by 2,6 times
(p = 0,003), and total health by 1,6 times (p = 0,03). Physical activity was restored in 90% of patients during the fi rst year.

Conclusion. The study shows signifi cant improvement in all QoL variables after heart transplantation in stage D heart failure patients. Main indices of physical, psychical, and social activities rise at the fi rst year and remain high during the 5-year period. These data support heart transplantation as a radical and effective method of terminal heart failure treatment.

About the Authors

A. O. Shevchenko
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation N.I. Pirogov Russian National Research Medical University, Moscow, Russian Federation
Russian Federation


T. A. Khalilulin
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation Department of transplantology and artifi cial organs, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Russian Federation


B. L. Mironkov
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation


R. Sh. Saitgareev
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation


V. M. Zakharevich
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation Department of transplantology and artifi cial organs, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Russian Federation


A. Ya. Kormer
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation


I. I. Muminov
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation


S. V. Gautier
V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
Russian Federation


References

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012; 14 (8): 803–869. doi: 10.1093/eurheartj/ehs104.

2. Karapolat H, Engin C, Eroglu M, Yagdi T, Zoghi M, Nalbantgil S et al. Effi cacy of the cardiac rehabilitation program in patients with end-stage heart failure, heart transplant patients, and left ventricular assist device recipients. Transplant Proc. 2013 Nov; 45 (9): 3381–3385.

3. Готье СВ, Шевченко АО, Попцов ВН. Пациент с трансплантированным сердцем. Руководство для врачей по ведению пациентов, перенесших трансплантацию сердца. М.–Тверь: Триада, 2014: 144. Gautier SV, Shevchenko AO, Poptsov VN. Patsient s transplantirovannym serdtsem. Rukovodstvo dlya vrachey po vedeniyu patsientov, perenesshikh transplantatsiyu serdtsa. M.–Tver': Triada, 2014: 144.

4. Мареев ВЮ, Агеев ФГ, Арутюнов ГП, Коротеев АВ, Мареев ЮВ, Овчинников АГ. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН. Сердечная недостаточность. 2013; 7 (81): 379–472. Mareev VYu, Ageev FG, Arutyunov GP, Koroteev AV, Mareev YuV, Ovchinnikov AG. Natsional'nye rekomendatsii OSSN, RKO i RNMOT po diagnostike i lecheniyu KhSN. Serdechnaya nedostatochnost'. 2013; 7 (81): 379–472.

5. Трансплантация сердца. Руководство для врачей / Под ред. С.В. Готье, В.Н. Попцова, А.О. Шевченко. М.–Тверь: Триада, 2014: 136. Transplantatsiya serdtsa. Rukovodstvo dlya vrachey / Pod red. S.V. Gautier, V.N. Poptsova, A.O. Shevchenko. M.–Tver': Triada, 2014: 136.

6. Ware JE, Sherboume CD. The MOS 36-item short-form health survey (SF-36): Conceptual framework and item selection. Mad Care. 1992; 30: 473–483.

7. Carels RA. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res. 2004; 13: 63–72.

8. Karapolat H, Eyigor S, Durmaz B et al. The relationship between depressive symptoms and anxiety and quality of life and functional capacity in heart transplant patients. Clin. Res. Cardiol. 2007; 96: 593–959.

9. Аронов ДМ. Методика оценки качества жизни у больных с сердечно-сосудистыми заболеваниями. Кардио логия. 2002; 5: 92–95. Aronov DM. Metodika otsenki kachestva zhizni u bol'nykh s serdechno-sosudistymi zabolevaniyami. Kardiologiya. 2002; 5: 92–95.

10. Galeone A, Kirsch M, Barreda E, Fernandez F et al. Clinical outcome and quality of life of patients surviving 20 years or longer after heart transplantation. Transpl Int. 2014; 27 (6): 576–582.

11. Kugler C, Bara C, von Waldthausen T et al. Association of depression symptoms with quality of life and chronic artery vasculopathy: a cross-sectional study in heart transplant patients. J Psychosom Res. 2014; 77 (2): 128–134.


Review

For citations:


Shevchenko A.O., Khalilulin T.A., Mironkov B.L., Saitgareev R.Sh., Zakharevich V.M., Kormer A.Ya., Muminov I.I., Gautier S.V. QUALITY OF LIFE ASSESSMENT IN CARDIAC TRANSPLANT RECIPIENTS. Russian Journal of Transplantology and Artificial Organs. 2014;16(4):11-16. (In Russ.) https://doi.org/10.15825/1995-1191-2014-4-11-16

Views: 2598


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)